48,000.00
-500.00
(-1.03%)
At close: January 10 at 3:36:08 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 3 | 6 | 8 |
| Avg. Estimate | 3.21B | 3.43B | 11.81B | 15.7B |
| Low Estimate | 2.82B | 2.83B | 11.35B | 13.61B |
| High Estimate | 3.51B | 3.78B | 12.04B | 16.89B |
| Year Ago Sales | 2.4B | 2.74B | 8.03B | 11.81B |
| Sales Growth (year/est) | 33.47% | 25.44% | 47.10% | 32.97% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NU.CL | -- | -- | -- | -- |
| S&P 500 | 8.59% | 11.42% | 13.98% | 13.43% |
Upgrades & Downgrades
| Downgrade | Citigroup: Neutral to Sell | 12/2/2024 |
| Maintains | Goldman Sachs: Buy to Buy | 11/14/2024 |
| Maintains | Keybanc: Overweight to Overweight | 11/14/2024 |
| Maintains | Susquehanna: Positive to Positive | 11/14/2024 |
| Maintains | B of A Securities: Neutral to Neutral | 9/12/2024 |
| Maintains | JP Morgan: Neutral to Neutral | 8/19/2024 |